Does PEMBROLIZUMAB Cause Febrile neutropenia? 1,223 Reports in FDA Database

Q: Does PEMBROLIZUMAB cause Febrile neutropenia?

1,223 reports of Febrile neutropenia have been filed with the FDA for PEMBROLIZUMAB, representing 1.5% of all PEMBROLIZUMAB adverse event reports.

Q: How dangerous is Febrile neutropenia from PEMBROLIZUMAB?

Of 1,223 reports, 187 (15.3%) resulted in death and 838 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,223 reports of Febrile neutropenia have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 1.5% of all adverse event reports for PEMBROLIZUMAB.

1,223

Reports of Febrile neutropenia with PEMBROLIZUMAB

1.5%

of all PEMBROLIZUMAB reports

187

Deaths

838

Hospitalizations

How Dangerous Is Febrile neutropenia From PEMBROLIZUMAB?

Of the 1,223 reports, 187 (15.3%) resulted in death, 838 (68.5%) required hospitalization, and 160 (13.1%) were considered life-threatening.